BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $258,000 | -11.0% | 3,000 | -16.7% | 0.04% | -17.4% |
Q3 2021 | $290,000 | 0.0% | 3,600 | 0.0% | 0.05% | 0.0% |
Q2 2021 | $290,000 | -4.6% | 3,600 | 0.0% | 0.05% | -13.2% |
Q1 2021 | $304,000 | +4.5% | 3,600 | 0.0% | 0.05% | +12.8% |
Q4 2020 | $291,000 | -11.0% | 3,600 | -11.3% | 0.05% | -23.0% |
Q3 2020 | $327,000 | -8.1% | 4,060 | -1.8% | 0.06% | -16.4% |
Q2 2020 | $356,000 | +6.0% | 4,136 | 0.0% | 0.07% | -12.0% |
Q1 2020 | $336,000 | -3.7% | 4,136 | -0.8% | 0.08% | +18.6% |
Q4 2019 | $349,000 | +7.4% | 4,170 | 0.0% | 0.07% | +2.9% |
Q3 2019 | $325,000 | -5.0% | 4,170 | 0.0% | 0.07% | -11.7% |
Q2 2019 | $342,000 | +4.9% | 4,170 | -2.3% | 0.08% | +4.1% |
Q1 2019 | $326,000 | +5.2% | 4,270 | 0.0% | 0.07% | -6.3% |
Q4 2018 | $310,000 | +19.7% | 4,270 | +5.4% | 0.08% | +27.4% |
Q3 2018 | $259,000 | -13.4% | 4,050 | 0.0% | 0.06% | -22.5% |
Q2 2018 | $299,000 | +5.7% | 4,050 | -6.9% | 0.08% | -1.2% |
Q1 2018 | $283,000 | -2.7% | 4,350 | -3.3% | 0.08% | -3.6% |
Q4 2017 | $291,000 | -9.3% | 4,500 | -15.1% | 0.08% | -22.2% |
Q3 2017 | $321,000 | 0.0% | 5,300 | 0.0% | 0.11% | +2.9% |
Q2 2017 | $321,000 | +21.6% | 5,300 | +3.9% | 0.10% | +9.4% |
Q1 2017 | $264,000 | +16.8% | 5,100 | 0.0% | 0.10% | +12.9% |
Q4 2016 | $226,000 | -9.6% | 5,100 | -2.9% | 0.08% | -15.0% |
Q3 2016 | $250,000 | +5.5% | 5,250 | 0.0% | 0.10% | +4.2% |
Q2 2016 | $237,000 | -55.9% | 5,250 | -59.9% | 0.10% | -58.4% |
Q1 2016 | $538,000 | +27.2% | 13,095 | +18.0% | 0.23% | +24.9% |
Q4 2015 | $423,000 | +31.8% | 11,095 | +13.5% | 0.18% | +27.6% |
Q3 2015 | $321,000 | -51.8% | 9,775 | +2.6% | 0.14% | -50.2% |
Q2 2015 | $666,000 | +9.0% | 9,530 | +6.8% | 0.29% | +6.2% |
Q1 2015 | $611,000 | -15.1% | 8,925 | -9.2% | 0.27% | -15.2% |
Q4 2014 | $720,000 | +11.1% | 9,825 | +8.9% | 0.32% | +8.0% |
Q3 2014 | $648,000 | +13.1% | 9,025 | +13.9% | 0.30% | +12.8% |
Q2 2014 | $573,000 | +45.4% | 7,925 | +48.1% | 0.26% | +33.8% |
Q1 2014 | $394,000 | +64.2% | 5,350 | +55.1% | 0.20% | +50.0% |
Q4 2013 | $240,000 | – | 3,450 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |